Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan.

Sharma, Arastu; Chabloz, Sophie; Lapides, Rebecca A; Roider, Elisabeth; Ewald, Collin Y

Sharma, Arastu; Chabloz, Sophie; Lapides, Rebecca A; Roider, Elisabeth; Ewald, Collin Y.

Afiliação

Sharma A; Laboratory of Extracellular Matrix Regeneration, Department of Health Sciences and Technology, Institute of Translational Medicine, ETH Zürich, 8603 Schwerzenbach, Switzerland.
Chabloz S; AVEA Life AG, Bahnhofplatz, 6300 Zug, Switzerland.
Lapides RA; AVEA Life AG, Bahnhofplatz, 6300 Zug, Switzerland.
Roider E; Department of Dermatology, University Hospital of Basel, 4031 Basel, Switzerland.
Ewald CY; Robert Larner, MD College of Medicine at the University of Vermont, Burlington, VT 05405, USA.

Nutrients ; 15(2)2023 Jan 14.

Article em En | MEDLINE | ID: mdl-36678315

Assuntos

NAD; Sirtuína 1; Humanos; Adolescente; NAD/metabolismo; Senoterapia; Niacinamida/farmacologia; Niacinamida/metabolismo; Mononucleotídeo de Nicotinamida; Nucleotídeos; Suplementos Nutricionais

Palavras-chave

NAD+; NMN; SIRT1; age-related diseases; aging; flavonoids; geroprotectors; healthspan; longevity; nutraceuticals; resveratrol; senolytics; supplements

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sirtuína 1 / NAD Limite: Adolescent / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google